FLR - Fluor awarded contracts of over $1B

2023-07-28 08:29:42 ET

• Fluor ( NYSE: FLR ) has been awarded a $487M biotech expansion project in Denmark and is also mobilizing resources in the central U.S. for the first phase of a new life sciences production facility valued at $574M.
• Fluor will recognize these reimbursable contracts in the second quarter backlog.
• “We are excited to see the significant investments being made globally in the production of cutting-edge technologies and pharmaceuticals that will improve the lives of billions of people,” said Richard Meserole, President of Fluor’s Advanced Technologies & Life Sciences business.

For further details see: